PUBLISHER: The Business Research Company | PRODUCT CODE: 1751125
PUBLISHER: The Business Research Company | PRODUCT CODE: 1751125
Spondylolisthesis is a spinal condition in which one vertebra slips forward over the one beneath it, leading to misalignment. This misalignment can cause back pain, stiffness, and nerve compression. It typically affects the lower spine and can result from factors such as aging, injury, or a congenital defect.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The main types of spondylolisthesis include degenerative, isthmic, congenital, traumatic, and pathological. Degenerative spondylolisthesis occurs when one vertebra slips forward over the one below it, often due to age-related changes in the spine, such as disc degeneration and arthritis. Treatment options for spondylolisthesis include both non-surgical and surgical approaches. Diagnosis typically involves X-rays, MRI (magnetic resonance imaging), CT scans (computed tomography), and physical examinations. These treatments and diagnostic methods are used in various healthcare settings, such as hospitals, ambulatory surgical centers (ASCs), specialty clinics, and rehabilitation centers.
The spondylolisthesis market research report is one of a series of new reports from The Business Research Company that provides spondylolisthesis market statistics, including the spondylolisthesis industry global market size, regional shares, competitors with the spondylolisthesis market share, detailed spondylolisthesis market segments, market trends, and opportunities, and any further data you may need to thrive in the spondylolisthesis industry. This spondylolisthesis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The spondylolisthesis market size has grown strongly in recent years. It will grow from$17.23 billion in 2024 to $18.24 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth during the historic period can be attributed to several factors, including advancements in imaging technologies leading to more frequent diagnoses, an aging global population, a rise in spinal surgeries, an increase in musculoskeletal disorders, and more sedentary lifestyles.
The spondylolisthesis market size is expected to see strong growth in the next few years. It will grow to$22.72 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The growth during the forecast period can be attributed to several factors, including an increase in sports and physical activity-related injuries, growing access to specialized spine care in emerging markets, ongoing research on biomechanical stability, a rise in desk-bound jobs and poor posture habits, and a higher incidence of chronic back pain and degenerative spine diseases. Major trends expected during this period include technological advancements in spinal implants and navigation, a shift toward minimally invasive spine surgery, growth in biologic and regenerative therapies, and the use of data-driven decision-making based on real-world evidence.
The growth of the spondylolisthesis market is expected to be driven by the expanding healthcare infrastructure. Healthcare infrastructure encompasses the necessary physical facilities, systems, and resources required to deliver effective healthcare services. The expansion of healthcare infrastructure is largely driven by the rising demand for accessible and advanced medical services, as existing facilities often struggle to accommodate the growing patient load and increasing complexity of care needed. Enhanced healthcare infrastructure supports the treatment of spondylolisthesis by ensuring the availability of medical facilities, skilled healthcare professionals, and proper distribution channels, all of which are critical for effective treatment and patient access to care. For example, according to the American Hospital Association, the United States had 6,120 hospitals in 2024, an increase from 6,093 in 2022. As such, the growth of healthcare infrastructure is a key factor in the expansion of the spondylolisthesis market.
Leading companies in the spondylolisthesis market are focusing on the integration of emerging technologies, such as advanced spinal implant systems, to improve surgical outcomes, maintain mobility, and enhance the overall quality of life for patients. These advanced spinal implant systems are designed to stabilize the spine while preserving its range of motion, offering a better alternative to traditional spinal fusion procedures. For instance, in June 2023, Premia Spine, a U.S.-based medical device company, received FDA approval for its TOPS System, marking it as the first lumbar spine implant to claim superiority over lumbar fusion for treating grade I degenerative spondylolisthesis with spinal stenosis. This groundbreaking technology transforms spinal surgery by replacing the damaged facet joint and lamina with a mechanical implant that allows controlled motion in various directions, including flexion, extension, lateral bending, and axial rotation. By preserving motion and stability, the TOPS System significantly reduces post-operative complications and recovery time. Its motion-preserving design eliminates the need for spinal fusion, offering patients an effective, less invasive treatment option with improved long-term mobility and functional outcomes.
In November 2023, Nevro Corp., a U.S.-based medical device company, acquired Vyrsa Technologies for an undisclosed amount. Through this acquisition, Nevro Corp. aims to expand its portfolio of chronic pain treatments by integrating Vyrsa Technologies' sacroiliac joint fusion solutions. This acquisition strengthens Nevro's position in the minimally invasive spine market and enhances its capacity to address a wider range of chronic pain conditions. Vyrsa Technologies is a U.S.-based medical technology company that specializes in minimally invasive solutions for spinal disorders.
Major players in the spondylolisthesis market are Johnson & Johnson, Medtronic plc, Stryker Corporation, Zimmer Biomet, Globus Medical, Orthofix Medical Inc., Alphatec Holdings, RTI Surgical, B. Braun AG, SeaSpine, SI-Bone, Spinal Elements, Surgalign, Sharma Orthopedic, Saluda Medical, Wenzel Spine, Premia Spine, Innovasis, SpineNet, VySpine.
North America was the largest region in the spondylolisthesis market in 2024. The regions covered in spondylolisthesis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the spondylolisthesis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The spondylolisthesis market consists of revenues earned by entities by providing services such as spinal fusion surgery, pain management, physical therapy, and neurological assessments. The market value includes the value of related goods sold by the service provider or included within the service offering. The spondylolisthesis market also include sales of spinal fusion implants, spinal plates and screws, and bone grafts and substitutes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Spondylolisthesis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on spondylolisthesis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for spondylolisthesis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The spondylolisthesis market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.